Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Response by Hänggi and Macdonald to Letter Regarding Article, "Randomized, Open-Label, Phase 1/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage])".

Literature DB >> 28283608

Response by Hänggi and Macdonald to Letter Regarding Article, "Randomized, Open-Label, Phase 1/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage])".

Daniel Hänggi¹, R Loch Macdonald².

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2017 PMID： 28283608 DOI： 10.1161/STROKEAHA.117.016603

Source DB: PubMed Journal: Stroke ISSN： 0039-2499 Impact factor: 7.914

Keyword Cloud
Cited

× No keyword cloud information.

1 in total

1. MEK1/2 inhibitor U0126, but not nimodipine, reduces upregulation of cerebrovascular contractile receptors after subarachnoid haemorrhage in rats.

Authors: Simon T Christensen; Sara E Johansson; Aneta Radziwon-Balicka; Karin Warfvinge; Kristian A Haanes; Lars Edvinsson
Journal: PLoS One Date: 2019-04-12 Impact factor: 3.240

1 in total